Mycosis Fungoides and Sezary Syndrome — Trials

Mycosis Fungoides and Sezary Syndrome — Trials · CancerIndex

Clinical trials

Registered studies

148 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 32
Recruiting: 15
Ph III recruiting: 0
Growth YoY: —
Industry share: 13%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 44.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (32)

clinicaltrialsPublishedShowing 51–61 of 61 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01396070	Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level	completed	Phase 2	36	Youn KimOTHER	1	Apr 5, 2017	clinicaltrials
NCT00226993	Phase I/II Study of Intratumoral Injection of CPG 7909, a TLR9 Agonist, Combined With Local Radiation for Patients With Recurrent Mycosis Fungoides.	withdrawn	Phase 1 / Phase 2	0	Stanford UniversityOTHER	0	Dec 1, 2016	clinicaltrials